NCT03446885View on ClinicalTrials.gov

Efficacy of Lisdexamfetamine Dimesylate for Promoting Occupational Success in Young Adults With ADHD

PHASE4CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

February 11, 2019

Study Completion Date

August 30, 2019

Conditions
Attention Deficit Disorder With Hyperactivity
Interventions
DRUG

Lisdexamfetamine Dimesylate 40 MG

Lisdexamfetamine Dimesylate 40 MG administered orally

DRUG

Placebo

Placebo capsule administered orally

Trial Locations (1)

14214

SUNY at Buffalo, Buffalo

All Listed Sponsors
lead

Gregory Fabiano

OTHER

NCT03446885 - Efficacy of Lisdexamfetamine Dimesylate for Promoting Occupational Success in Young Adults With ADHD | Biotech Hunter | Biotech Hunter